-+ 0.00%
-+ 0.00%
-+ 0.00%

Allogene prices 87,500,000-share follow-on offering at $2 per share

PUBT·04/15/2026 01:50:12
Listen to the news
Allogene prices 87,500,000-share follow-on offering at $2 per share
  • Allogene Therapeutics priced an underwritten public offering of 87,500,000 common shares at USD 2 per share.
  • Gross proceeds expected at USD 175 million before underwriting discounts and offering costs.
  • Deal expected to close on April 16, 2026, subject to customary closing conditions.
  • Underwriters received a 30-day option to buy up to 13,125,000 additional common shares.
  • Net proceeds earmarked for general corporate purposes, including clinical trials and R&D.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604142150PRIMZONEFULLFEED9690107) on April 15, 2026, and is solely responsible for the information contained therein.